Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - [Docket No. FDA-2008-N-0043]
          - [FDA No. 225-08-8001]

# AGENCY:

Food and Drug Administration, HHS.

# ACTION:

Notice.

# SUMMARY:

The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between FDA and the University of Pennsylvania (Penn). The purpose of this MOU is to establish terms of collaboration between FDA and Penn focused primarily but not exclusively, in the areas of translational therapeutics, diagnostics, bioinformatics, new clinical trial models, drug/device co-development, and pharmacoepidemiology. Beyond the collaborations in the traditional academic programs for training, research, and outreach, this MOU will also include collaborations with Penn extended partnerships such as the Institute for Translational Medicine and Therapeutics which includes the Children's Hospital of Philadelphia, the Wistar Institute, and the University of Sciences in Philadelphia.

# DATES:

The agreement became effective on July 24, 2008.

# FOR FURTHER INFORMATION CONTACT:

*For FDA*: Wendy R. Sanhai, Office of the Commissioner, Office of Scientific and Medical Programs (HF-18), Food and Drug                               ( print page 52386)                            Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7867.                    

*For Penn*: Glenn N. Gaulton, PENN Medicine, University of Pennsylvania, 421 Curie Blvd., Philadelphia, PA 19104-6160, 215-898-2874.                    

# SUPPLEMENTARY INFORMATION:

                    In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the                     **Federal Register**                    , the agency is publishing notice of this MOU.                

Dated: September 2, 2008.

Jeffrey Shuren,

Associate Commissioner for Policy and Planning.

      ( print page 52387)          ( print page 52388)          ( print page 52389)          ( print page 52390)          ( print page 52391)          ( print page 52392)    

BILLING CODE 4160-01-S

[FR Doc. E8-20932 Filed 9-8-08; 8:45 am]

BILLING CODE 4160-01-C